Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis.
Okamoto H, Shibazaki N, Yoshimura T, Uzawa T, Sugimoto T. Okamoto H, et al. Among authors: sugimoto t. Osteoporos Sarcopenia. 2020 Mar;6(1):15-19. doi: 10.1016/j.afos.2020.02.001. Epub 2020 Mar 5. Osteoporos Sarcopenia. 2020. PMID: 32226828 Free PMC article.
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
Mori S, Hagino H, Sugimoto T, Tanaka S, Mitomo Y, Takahashi K, Sone T, Nakamura T, Soen S. Mori S, et al. Among authors: sugimoto t. Osteoporos Int. 2023 Jan;34(1):189-199. doi: 10.1007/s00198-022-06570-0. Epub 2022 Oct 14. Osteoporos Int. 2023. PMID: 36239756 Free PMC article. Clinical Trial.
Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study.
Kumagai Y, Ose A, Tanaka K, Sugimoto T. Kumagai Y, et al. Among authors: sugimoto t. Clin Pharmacol Drug Dev. 2020 Jan;9(1):87-96. doi: 10.1002/cpdd.687. Epub 2019 Mar 28. Clin Pharmacol Drug Dev. 2020. PMID: 30921502 Free PMC article. Clinical Trial.
3,558 results